FindTrial
Sign In

A medical records based retrospective study on the effectiveness of vitamin B12 treatment for methylmalonic acidemia combined with homocysteinemia (CblC type)

Study on the effectiveness of vitamin B12 treatment for methylmalonic acidemia combined with homocysteinemia (CblC type)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047709
Enrollment
Unknown
Registered
2021-06-23
Start date
2021-06-23
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methylmalonic acidemia combined with homocysteinemia (CblC type)

Interventions

Case series:No

Sponsors

Neonatal intensive care unit of the Faculty of Pediatrics, the Seventh Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The infants were genetically diagnosed as methylmalonic acidemia combined with homocysteinemia (CblC type); 2. Received vitamin B12 treatment during hospitalization.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

MeasureTime frame
Propionyl carnitine;Homocysteine;—

Countries

China

Contacts

Public ContactMei Yabo

Neonatal intensive care unit of the Faculty of Pediatrics, the Seventh Medical Center of PLA General Hospital

myb2003@163.com+86 13641276932

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026